Showing results (41-50 of 49) with videos related to
Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
JCO Clinical Cancer Informatics|March 17, 2023
Using Recurrent Neural Networks to Extract High-Quality Information From Lung Cancer Screening Computerized Tomography Reports for Inter-Radiologist Audit and Feedback Quality ImprovementYucheng Zhang, Benjamin M M Grant, Andrew J Hope, et al.Thorax|January 9, 2024
Radiomics analysis to predict pulmonary nodule malignancy using machine learning approachesMatthew T Warkentin, Hamad Al-Sawaihey, Stephen Lam, et al.Journal of the National Cancer Institute|June 27, 2023
Circulating proteome for pulmonary nodule malignancyElham Khodayari Moez, Matthew T Warkentin, Yonathan Brhane, et al.Clinical Genitourinary Cancer|October 14, 2025
CABOSEQ 3-Comparison of Cabozantinib versus Sunitinib Following First-Line Nivolumab- Ipilimumab for Metastatic Renal Cell Carcinoma: A Target Trial Emulation Using Real-World Data from the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC)Audreylie Lemelin, David Maj, Kosuke Takemura, et al.Journal of Hospital Medicine|August 30, 2022
Variation in the risk of death due to COVID-19: An international multicenter cohort study of hospitalized adultsKieran L Quinn, Husam Abdel-Qadir, Kali Barrett, et al.Journal of the Canadian Association of Gastroenterology|April 30, 2026
Should we screen for colorectal cancer with biennial FIT beginning at age 45 in Canada?Linda Rabeneck, Jill Tinmouth, John M Hutchinson, et al.Cancer Research|January 21, 2021
Assessing Lung Cancer Absolute Risk Trajectory Based on a Polygenic Risk ModelRayjean J Hung, Matthew T Warkentin, Yonathan Brhane, et al.Nature Communications|January 9, 2020
Immune-mediated genetic pathways resulting in pulmonary function impairment increase lung cancer susceptibilityLinda Kachuri, Mattias Johansson, Sara R Rashkin, et al.Annals of Epidemiology|November 21, 2022
Design and methodological considerations for biomarker discovery and validation in the Integrative Analysis of Lung Cancer Etiology and Risk (INTEGRAL) ProgramHilary A Robbins, Karine Alcala, Elham Khodayari Moez, et al.Pageof 5